Internal Medicine, Gastroenterology · New Orleans, LA
NPI
1174637300
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
3
Medicare group memberships
Hospitals
3
Hospital affiliations
2000 Canal St Fl 5
New Orleans, LA, 70112
Phone (504) 962-6099
Groups this clinician bills Medicare through
Medicare paid, 2024
$20K
271 services
Medicare patients, 2024
114
Average age 62
Drug cost, 2024
$3.4M
740 prescriptions
Company payments, 2025
$50K
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sarah C Glover was code 99214 (office e&m - established), 80 times for 39 patients. In total Sarah C Glover billed 271 services in 26 codes, and Medicare paid $20K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-02-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 80 | 39 | $69.87 | $5,589 |
| 99222 Hospital E&M - Initial | Facility | 55 | 35 | $100.27 | $5,515 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 44 | 33 | $12.62 | $555 |
| 99204 Office E&M - New | Facility | 16 | 16 | $96.68 | $1,547 |
| 43239 Upper GI Endoscopy | Facility | 13 | 12 | $70.21 | $913 |
| 45380 Lower GI Endoscopy - Other | Facility | 13 | 13 | $119.32 | $1,551 |
By year: 2022 $60K for 741 services; 2023 $22K for 306 services; 2024 $20K for 271 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sarah C Glover prescribed most often to Medicare patients was Stelara (Ustekinumab), with 61 prescriptions and refills. In total Sarah C Glover wrote 740 Medicare prescriptions that cost $3.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Stelara Ustekinumab | 61 | 91 | 21 | $1.6M |
| Sodium Chloride 0.9 % Sodium Chloride | 55 | 55 | Under 11 | $1,268 |
| Omeprazole Generic | 47 | 77 | 16 | $513 |
| Entyvio Vedolizumab | 41 | 52 | Under 11 | $361K |
| Ondansetron Hcl Ondansetron Hcl/Pf | 31 | 31 | Under 11 | $312 |
| Tacrolimus Generic | 31 | 37 | 12 | $2,680 |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 26 | 26 | Under 11 | $1,000 |
| Diphenhydramine Hcl Generic | 24 | 24 | Under 11 | $1,118 |
| Loperamide Loperamide Hcl | 22 | 26 | Under 11 | $1,020 |
| Pantoprazole Sodium Generic | 22 | 48 | Under 11 | $151 |
| Ondansetron Odt Ondansetron | 20 | 20 | Under 11 | $230 |
| Gattex Teduglutide | 20 | 20 | Under 11 | $922K |
| Methylprednisolone Sodium Succ Methylprednisolone Sod Succ | 19 | 19 | Under 11 | $128 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 17 | 17 | 17 | $977 |
| Magnesium Sulfate Generic | 15 | 15 | Under 11 | $1,562 |
Brand drugs: 298 claims; generic drugs: 442 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sarah C Glover $50K ($50K in general payments such as food, travel and fees) from 22 companies. The largest payer was Janssen Research & Development, LLC with $38K.
| Company | Payments | Amount |
|---|---|---|
| Janssen Research & Development, LLC JNJ | 5 | $38K |
| Merck Sharp & Dohme LLC MRK | 9 | $8,403 |
| Janssen Biotech, Inc. JNJ | 11 | $471 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 29 | $457 |
| Abbvie Inc. ABBV | 32 | $447 |
| Janssen Scientific Affairs, LLC JNJ | 3 | $402 |
| Genzyme Corporation SNY | 9 | $264 |
| Fujifilm Healthcare Americas Corporation | 2 | $216 |
| Pfizer Inc. PFE | 14 | $214 |
| Mallinckrodt Hospital Products Inc. | 5 | $213 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.